Mydecine, JHU Expand Pact Focused Initially On Smoking Cessation Mydecine Innovations Group Inc. and Johns Hopkins University said on 18 August that they will undertake a five-year collaboration t
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Eisai To Sell Kyorin’s OAB Agent In Fou
Pharmaceuticals Alnara Pharmaceuticals Inc. Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics Inc. Alnara secures exclusive global license to CFFT's liprotamase March — Alnara Pharma